Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Han van den Bosch"'
Autor:
Ethlinn V.B. van Gaal, Niels Hagenaars, Rolf J. Verheul, Wim E. Hennink, Thomas van Es, J.G.M. Heldens, Han van den Bosch, Bram Slütter, Pascal H.J.L.F. de Jong, Harrie L. Glansbeek, Enrico Mastrobattista, Ivo Que, Wim Jiskoot, Sven C. M. Bruijns
Publikováno v:
Verheul, R J, Hagenaars, N, van Es, T, van Gaal, E V B, De Jong, P H J L, Bruijns, S C M, Mastrobattista, E, Slutter, B, Que, I, Heldens, J G M, van den Bosch, J F, Glansbeek, H L, Hennink, W E & Jiskoot, W 2012, ' A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine ', European Journal of Pharmaceutical Sciences, vol. 45, no. 4, pp. 467-474 . https://doi.org/10.1016/j.ejps.2011.10.001
European Journal of Pharmaceutical Sciences, 45(4), 467-474. Elsevier
European Journal of Pharmaceutical Sciences, 45(4), 467-474
European Journal of Pharmaceutical Sciences, 45(4), 467-474. Elsevier
European Journal of Pharmaceutical Sciences, 45(4), 467-474
Recently we reported that reacetylation of N,N,N-trimethyl chitosan (TMC) reduced the adjuvant effect of TMC in mice after intranasal (i.n.) administration of whole inactivated influenza virus (WIV) vaccine. The aim of the present study was to elucid
Autor:
Alexander Mironov, Natalie Larionova, Han van den Bosch, Irina Kiseleva, Dimitry Bushmenkov, Larisa Rudenko, A. N. Naikhin
Publikováno v:
Vaccine, 29(S1):A40-A44
Rudenko, L, Kiseleva, I, Mironov, A, Naikhin, A, Larionova, N V, Bushmenkov, D & van den Bosch, H 2011, ' Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries ', Vaccine, vol. 29, no. 1 . https://doi.org/10.1016/j.vaccine.2011.04.122
Vaccine, 29(1). Elsevier BV
Rudenko, L, Kiseleva, I, Mironov, A, Naikhin, A, Larionova, N V, Bushmenkov, D & van den Bosch, H 2011, ' Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries ', Vaccine, vol. 29, no. 1 . https://doi.org/10.1016/j.vaccine.2011.04.122
Vaccine, 29(1). Elsevier BV
In February 2009, Nobilon granted the World Health Organization (WHO) a non-exclusive licence to develop, register, manufacture, use and sell seasonal a pandemic live attenuated influenza vaccine (LAIV) produced on embryonated chicken eggs. WHO was p
Autor:
Irina Kiseleva, Han van den Bosch, Jacco G. M. Heldens, Stephanie M. C. Basten, J. Theo M. Voeten, N V Larionova, Sandra K. M. Drieszen-van der Cruijsen, L. C. P. Teley, Larisa Rudenko
Publikováno v:
Kiseleva, I V, Voeten, J T, Teley, L C, Larionova, N V, Drieszen-van der Cruijsen, S K, Basten, S M, Heldens, J G, van den Bosch, H & Rudenko, L G 2010, ' PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus ', Journal of General Virology, vol. 91, pp. 931-937 . https://doi.org/10.1099/vir.0.017996-0
Journal of General Virology, 91, 931-937. Society for General Microbiology
Journal of General Virology, 91, 931-937. Society for General Microbiology
The cold-adapted (ca) and temperature-sensitive (ts) influenza master donor virus (MDV) B/USSR/60/69 was derived from its wild-type parental virus after successive passages in eggs at 32 degrees C and 25 degrees C. This strain is currently in use for
Autor:
Pascal H.J.L.F. de Jong, Niels Hagenaars, Enrico Mastrobattista, J.G.M. Heldens, Harrie L. Glansbeek, Rolf J. Verheul, Imke Mooren, Wim E. Hennink, Han van den Bosch, Wim Jiskoot
Publikováno v:
Journal of Controlled Release. 140:126-133
The aim of this study was to assess the influence of structural properties of N,N,N-trimethyl chitosan (TMC) on its adjuvanticity. Therefore, TMCs with varying degrees of quaternization (DQ, 22-86%), O-methylation (DOM, 0-76%) and acetylation (DAc 9-
Autor:
Niels Hagenaars, Herman Vromans, Enrico Mastrobattista, Virgil E.J.C. Schijns, Harrie L. Glansbeek, Wim Jiskoot, Han van den Bosch, Didier Betbeder, J.G.M. Heldens
Publikováno v:
Vaccine. 26:6555-6563
In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split,
Autor:
Joachim Frey, Han van den Bosch
Publikováno v:
Vaccine. 21:3601-3607
The role of antibodies to the outer membrane protein PalA of Actinobacillus pleuropneumoniae in protective immunity was studied in pigs vaccinated with purified PalA alone and PalA in combination with toxoids of the RTX toxins ApxI and ApxII using an
Autor:
Larissa Rudenko, Pierre Van Damme, Theo Voeten, J.G.M. Heldens, Belinda Breedveld, Wilbert van Duijnhoven, Pierre Verweij, Han van den Bosch, Ellen G. J. Hulskotte
Publikováno v:
Vaccine
Live attenuated influenza vaccine (LAIV) offers the promise of inducing a variety of immune responses thereby conferring protection to circulating field strains. LAIVs are based on cold adapted and temperature sensitive phenotypes of master donor vir
Autor:
Jessica A. Belser, Taronna R. Maines, J. Theo M. Voeten, Jacqueline M. Katz, J.G.M. Heldens, Neal Van Hoeven, Xuihua Lu, Libo Dong, Ruben O. Donis, Alexander Klimov, Li-Mei Chen, Nancy J. Cox, Terrence M. Tumpey, Larisa Rudenko, Irina Isakova-Sivak, Han van den Bosch, Kortney M. Gustin
Publikováno v:
Gustin, K M, Maines, T R, Belser, J A, van Hoeven, N, Lu, X, Dong, L, Isakova-Sivak, I, Chen, L M, Voeten, J T, Heldens, J G, van den Bosch, J F, Cox, N J, Tumpey, T M, Klimov, A I, Rudenko, L, Donis, R O & Katz, J M 2011, ' Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets ', Journal of Infectious Diseases . https://doi.org/10.1093/infdis/jir596
Journal of Infectious Diseases. Oxford University Press
Journal of Infectious Diseases. Oxford University Press
Continued H5N1 virus infection in humans highlights the need for vaccine strategies that provide cross-clade protection against this rapidly evolving virus. We report a comparative evaluation in ferrets of the immunogenicity and cross-protective effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca8efae27fecb3899b1a9749906103ed
https://hdl.handle.net/1871.1/4fcab963-96cb-4e25-81a7-9d8e1abcb103
https://hdl.handle.net/1871.1/4fcab963-96cb-4e25-81a7-9d8e1abcb103
Autor:
Niels Hagenaars, Clemens W.G.M. Löwik, Jacco G. M. Heldens, Harrie L. Glansbeek, Han van den Bosch, Wim Jiskoot, Bram Slütter, Eric L. Kaijzel, Rob Nieuwland, Ivo Que, Enrico Mastrobattista, Pascal H.J.L.F. de Jong, Marta Mania
Publikováno v:
Journal of Controlled Release, 144(1), 17-24
Journal of Controlled Release, 144(1), 17-24. Elsevier
Hagenaars, N, Mania, M, De Jong, P, Que, I, Nieuwland, R, Slütter, B, Glansbeek, H, Heldens, J, van den Bosch, H, Löwik, C, Kaijzel, E L, Mastrobattista, E & Jiskoot, W 2010, ' Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine ', Journal of Controlled Release, vol. 144, no. 1, pp. 17-24 . https://doi.org/10.1016/j.jconrel.2010.01.027
Journal of Controlled Release, 144(1), 17-24. Elsevier
Hagenaars, N, Mania, M, De Jong, P, Que, I, Nieuwland, R, Slütter, B, Glansbeek, H, Heldens, J, van den Bosch, H, Löwik, C, Kaijzel, E L, Mastrobattista, E & Jiskoot, W 2010, ' Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine ', Journal of Controlled Release, vol. 144, no. 1, pp. 17-24 . https://doi.org/10.1016/j.jconrel.2010.01.027
The nose is a promising immunization site and intranasal (in.) vaccination studies with whole inactivated influenza virus (WIV) adjuvanted with N,N,N-trimethylchitosan (TMC-WIV) have shown promising results. In this study, the influence of TMC on the
Autor:
Enrico Mastrobattista, Niels Hagenaars, Rolf J. Verheul, Wim Jiskoot, Han van den Bosch, J.G.M. Heldens, Imke Mooren, Harrie L. Glansbeek
Publikováno v:
Pharmaceutical research. 26(6)
The purpose of this study was the development and physicochemical and immunological characterization of intranasal (i.n.) vaccine formulations of whole inactivated influenza virus (WIV) coated with N,N,N-trimethyl chitosan (TMC).Synthesized TMCs with